XIV News Alert Daily Inverse VIX ST ETN Velocityshares (XIV)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Daily Inverse VIX ST ETN Velocityshares (XIV) 29.40 $XIV

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Pullback After Gaining 6.12% Yesterday
Comtex SmarTrend(R) - Thu Feb 12, 3:57PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $27.89 to a high of $29.18. Yesterday, the shares gained 6.1%, which took the trading range above the 3-day high of $27.68 on volume of 17.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 29.40 (+0.35)

Downtrend Call Working As VelocityShares Daily Inverse VIX ST ETN Stock Falls 23.2% (XIV)
Comtex SmarTrend(R) - Wed Feb 11, 4:56PM CST
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on December 10th, 2014 at $35.66. In approximately 2 months, VelocityShares Daily Inverse VIX ST ETN has returned 23.25% as of today's recent price of $27.37.
XIV: 29.40 (+0.35)

U.S. Equity Volatility Is 'Back To Average'
ValueWalk - at Seeking Alpha - Wed Feb 11, 3:30AM CST
By Michael Ide Morgan Stanley says that it's understandable that volatility us up for most asset classes, but sees room for US equity volatility to fall again. Volatility is up across the board, in some cases from historic lows to recent highs,...
TVIX: 2.57 (-0.05), VXX: 30.97 (-0.38), IVOP: 37.88 (-0.16), UVXY: 22.57 (-0.61), VIIX: 41.82 (-0.49), XXV: 38.25 (unch), VIXY: 20.59 (-0.25), SVXY: 57.74 (+0.73), XIV: 29.40 (+0.35)

Short-Term VIX Futures Products Should Be Avoided Until Better Opportunities Arise
Nathan Buehler - at Seeking Alpha - Mon Feb 09, 2:03PM CST

VXX: 30.97 (-0.38), UVXY: 22.57 (-0.61), XIV: 29.40 (+0.35), SVXY: 57.74 (+0.73)

After Yesterday's Decline of 4.24%, VelocityShares Daily Inverse VIX ST ETN Offers Investors Better Value
Comtex SmarTrend(R) - Fri Feb 06, 3:38PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $26.06 to a high of $28.36. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $26.61 on volume of 30.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 29.40 (+0.35)

iPath S&P 500 VIX - Why I'm Selling The VIX Here
Markos Kaminis - at Seeking Alpha - Wed Feb 04, 1:13PM CST

TVIX: 2.57 (-0.05), MTUM: 70.13 (+0.09), SPY: 209.78 (+0.86), VXX: 30.97 (-0.38), ZIV: 40.78 (+0.37), UVXY: 22.57 (-0.61), OIL: 12.01 (+0.34), NBG: 1.61 (+0.18), XIV: 29.40 (+0.35)

Shares of XIV Down 22.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 04, 11:14AM CST
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on December 10th, 2014 at $35.66. In approximately 2 months, VelocityShares Daily Inverse VIX ST ETN has returned 22.41% as of today's recent price of $27.67.
XIV: 29.40 (+0.35)

Volatility Is Whipsawing Investors, Which Side Are You On?
Josh Arnold - at Seeking Alpha - Tue Feb 03, 8:17PM CST

VXX: 30.97 (-0.38), XIV: 29.40 (+0.35)

SmarTrend Watching for Potential Rebound in Shares of VelocityShares Daily Inverse VIX ST ETN After 10.24% Loss
Comtex SmarTrend(R) - Fri Jan 30, 3:39PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $24.80 to a high of $27.47. Yesterday, the shares fell 10.2%, which took the trading range below the 3-day low of $26.06 on volume of 39.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 29.40 (+0.35)

14.8% Return Seen to Date on SmarTrend VelocityShares Daily Inverse VIX ST ETN Call (XIV)
Comtex SmarTrend(R) - Wed Jan 28, 10:05AM CST
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on December 10th, 2014 at $35.66. In approximately 2 months, VelocityShares Daily Inverse VIX ST ETN has returned 14.81% as of today's recent price of $30.38.
XIV: 29.40 (+0.35)

The Year In VIX And Volatility - 2014
Bill Luby - at Seeking Alpha - Mon Jan 26, 11:05PM CST
This is the seventh year in a row I have offered a retrospective look at the year in VIX and Volatility, which is my attempt to cram some of the highlights of the year in volatility onto one graphic with a (somewhat) manageable number of annotations....
TVIZ: 21.76 (-1.84), TVIX: 2.57 (-0.05), XVZ: 28.30 (-0.18), VIXM: 63.82 (-0.30), XVIX: 16.10 (-0.06), ZIV: 40.78 (+0.37), VXX: 30.97 (-0.38), IVOP: 37.88 (-0.16), UVXY: 22.57 (-0.61), VIIX: 41.82 (-0.49), CVOL: 0.95 (-0.04), VXZ: 13.10 (-0.08), VIIZ: 19.06 (+0.09), XXV: 38.25 (unch), VIXY: 20.59 (-0.25), SVXY: 57.74 (+0.73), XIV: 29.40 (+0.35)

VelocityShares Daily Inverse VIX ST ETN Rises 4.61% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jan 26, 3:46PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $29.51 to a high of $31.21. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $31.09 on volume of 17.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XIV: 29.40 (+0.35)

VelocityShares Daily Inverse VIX ST ETN Has Returned 24.8% Since SmarTrend Recommendation (XIV)
Comtex SmarTrend(R) - Wed Jan 14, 9:24AM CST
SmarTrend identified a Downtrend for VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) on December 10th, 2014 at $35.66. In approximately 1 month, VelocityShares Daily Inverse VIX ST ETN has returned 24.79% as of today's recent price of $26.82.
XIV: 29.40 (+0.35)

One Reason Why The New VIX Calculation Is Better
Vance Harwood - at Seeking Alpha - Tue Jan 13, 5:02PM CST
The CBOE changed the way the VIX® was calculated on October 6th, 2014- asserting the change would provide a more accurate assessment of expected volatility. The new process does look better to me, but I've been surprised that the new VIX and the...
TVIZ: 21.76 (-1.84), TVIX: 2.57 (-0.05), XVZ: 28.30 (-0.18), VIXM: 63.82 (-0.30), XVIX: 16.10 (-0.06), ZIV: 40.78 (+0.37), VXX: 30.97 (-0.38), IVOP: 37.88 (-0.16), UVXY: 22.57 (-0.61), VIIX: 41.82 (-0.49), CVOL: 0.95 (-0.04), VXZ: 13.10 (-0.08), VIIZ: 19.06 (+0.09), XXV: 38.25 (unch), VIXY: 20.59 (-0.25), SVXY: 57.74 (+0.73), XIV: 29.40 (+0.35)

Watch for VelocityShares Daily Inverse VIX ST ETN to Potentially Rebound After Falling 4.90% Yesterday
Comtex SmarTrend(R) - Mon Jan 12, 11:14PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $28.18 to a high of $30.23. Yesterday, the shares fell 4.9%, which took the trading range below the 3-day low of $29.00 on volume of 23.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 29.40 (+0.35)

SmarTrend Watching for Potential Rebound in Shares of VelocityShares Daily Inverse VIX ST ETN After 2.44% Loss
Comtex SmarTrend(R) - Tue Jan 06, 3:50PM CST
VelocityShares Daily Inverse VIX ST ETN (NYSE:XIV) traded in a range yesterday that spanned from a low of $27.75 to a high of $30.05. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $29.01 on volume of 38.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XIV: 29.40 (+0.35)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 16

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 13

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Niterra and Rackspace: Seamless Migration to Google Cloud

Updated Category News Views 126

Niterra and Rackspace: A Strategic Partnership for Cloud Migration Niterra EMEA GmbH has taken a monumental step in its digital transformation journey by partnering with Rackspace Technology. This collaboration aims to enhance operational efficiency through a swift migration to Google Cloud, capitalizing on Rackspace's extensive expertise in handling business-critical...

Continue Reading
Sweden Procures Four C-390 Millennium Aircraft from Embraer

Updated Category News Views 123

Sweden's Announcement on C-390 Millennium Acquisition In a significant development for military aviation, Sweden has officially committed to acquiring four C-390 Millennium multi-mission aircraft from Embraer. This strategic move is expected to enhance Sweden's defense capabilities and interoperability within NATO. Details of the Agreement The acquisition announcement...

Continue Reading
MindMed Initiates Phase 3 Study for MM120 in Anxiety Treatment

Updated Category News Views 332

MindMed Begins Journey with Phase 3 Study of MM120 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has crossed a significant milestone in its mission to provide breakthrough treatments for brain health disorders. The clinical-stage biopharmaceutical company has announced that the first patient is now dosed in its pivotal Phase 3 Voyage study of MM120 Orally Disintegrating...

Continue Reading
Global Office Furniture Market Set to Expand Significantly

Updated Category News Views 62

Growth Overview of the Office Furniture Market The global office furniture market is currently experiencing steady growth, fueled by the rising popularity of flexible and hybrid work environments. This shift is creating a strong demand for adaptable and ergonomic furniture that works well in both home and office contexts. As businesses evolve and expand, there’s an...

Continue Reading
Understanding Fiscal Dominance and Its Impact on Bond Markets

Updated Category News Views 467

Understanding Fiscal Dominance and Its Effects Fiscal dominance is an increasingly important concept in today's economic discussions, especially for those keen on understanding market dynamics. This economic principle involves a scenario where ongoing primary fiscal deficits stimulate nominal growth while the Central Bank maintains a loose monetary policy, failing to...

Continue Reading